Shareholders Approve Equity Plan Authorizing Over 8 Million Shares, Potential 23% Dilution
QLYS sits 49% above its 52-week low of $74.51.
Summary
Qualys shareholders approved an amended equity incentive plan authorizing up to 8,193,691 additional shares for future grants, representing a potential dilution of approximately 23% for existing shareholders.
Key Events · Corporate Governance and Compliance · QLYS
-
Equity Incentive Plan Approved
Stockholders approved the 2012 Equity Incentive Plan, as amended and restated, which authorizes the issuance of up to 8,193,691 additional shares for various equity awards.
-
Potential Dilution
If all authorized shares under the newly approved plan were issued, it would result in a potential dilution of approximately 23.22% based on the company's current outstanding shares.
-
Annual Meeting Results
The company held its 2026 annual meeting on June 10, 2026, with approximately 90.60% of shares outstanding represented.
-
Routine Approvals
Stockholders re-elected three Class II directors, ratified Grant Thornton LLP as the independent registered public accounting firm for fiscal year 2026, and provided advisory approval for executive compensation.
Analysis · QLYS · Technology
The approval of the amended equity incentive plan provides Qualys with a substantial pool of shares for future compensation, which could lead to significant dilution for existing shareholders if fully utilized. While essential for attracting and retaining talent, the authorization of over 8 million shares represents a notable increase in potential share count relative to the company's current outstanding shares.
At the time of this filing, QLYS was trading at $110.83 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $74.51 to $155.47. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.